Africa bears 25% of the global disease burden despite representing less than 20% of the world's population, yet produces less than 6% of its medical supplies, only about one-third of its pharmaceutical needs, and merely 1% of the vaccines it consumes; this structural vulnerability, highlighted during the COVID-19 pandemic, has prompted Kenya to pursue becoming a regional pharmaceutical hub by strengthening its regulatory authority to achieve WHO maturity level three, aiming to address the continent's pharmaceutical expenditure disparity of approximately $25 per capita compared to the global average of over $160.
Approfondir
Prérequis
- Pas de données disponibles.
Prochaines étapes
- Pas de données disponibles.
Approfondir
President William Ruto pushes Kenya’s bid to become a regional pharmaceutical hubAjouté :
news desk and we go to our next where President William Ruto earlier today addressed the Africa initiative for medical access and manufacturing on the sidelines of the Africa forward summit currently being held in Nairobi.
President Ruto highlighted the goal to position Kenya as a regional hub for pharmaceutical manufacturing, health innovation, and medical supply chains serving both the Kenyan and the wider African markets. He added that Kenya is taking deliberate steps to strengthen its pharmaceutical ecosystem by enhancing the capacity of the national regulatory authority to achieve World Health Organization maturity level three, thereby reinforcing global confidence in the quality, safety, and efficacy of Kenyan manufactured products.
Africa bears as has been said here earlier 25% of the global disease burden despite accounting for less than 20% of the world's population.
Yet, our continent still produces less than 6% of its medical supplies, only about 1/3 of its pharmaceutical needs, and a mere 1% of the vaccines it consumes.
And this was starkly reminded to us during the time of COVID.
This is more than a health gap.
It is a structural vulnerability.
Africa's pharmaceutical expenditure stands at approximately $25 per capita compared to a global average of more than $160.
That disparity reflects not only constrained access, but also underdeveloped markets and limited industrial capacity.
Across the continent nearly 700 pharmaceutical manufacturers exist including in Kenya. Yet, most remain small and middle and mid-size, fragmented, and concentrated in only a handful of countries.
This limits scale, limits competitiveness, resilience, and our ability to respond effectively to present and future crisis.
Vidéos Similaires
JPMorgan CEO JUST NUKED Mamdani... as NYC's Middle Class COLLAPSES
Englishman-In-NewYork
7K views•2026-05-30
Why Canadians can no longer afford to survive #canada #inflation #shorts
TrueNorthInvestor-v4j
131 views•2026-06-01
The Hidden Difference Between Breakouts & Real Moves #trading #orderflow
SmartMoneyFutures
272 views•2026-06-02
What has a broader economic impact, corporate downsizing or ecological collapse?
theratracejournal
1K views•2026-05-29
China Is Quietly Buying Gold, the Iran Deal Is Frozen, and Silver Is Heating Up
RichardHolloway0
694 views•2026-05-31
Uranium Isn’t Priced Like Other Metals
vricmedia
929 views•2026-06-02
I Think Oil Futures Dropped Before Trump’s Iran Statement — And Here’s Why
bradicemancolbert
709 views•2026-06-02
After waiting 90 minutes, CA mom and baby leave ER before treatment. Then came a $4.9K bill.
abc7news
290 views•2026-06-04
Tendances
Why Batman Lets The Joker Live 🤨
zackdfilms
9222K views•2026-05-30
They're Complete Trash
penguinz0
558K views•2026-06-04
The Murder of Deputy Caleb Conley
MidwestSafety
810K views•2026-06-04
I Bought FAKE HopeScope Merch (and paid a subscriber to give it a makeover) | Hopeful Hauls
HangWithHopescope
158K views•2026-06-04











